[Chronic Obstructive Pulmonary Disease]

Area of Science:

• Respiratory Medicine
• Pulmonology
• Clinical Science

Context:

• Chronic Obstructive Pulmonary Disease (COPD) is a major health concern, primarily linked to smoking but influenced by multiple risk factors.
• Accurate diagnosis relies on persistent respiratory symptoms, risk exposure, and irreversible obstructive spirometry, yet underdiagnosis remains significant.
• Current diagnostic methods necessitate spirometry, prompting research into alternative screening approaches.

Purpose:

• To explore advancements in personalized medicine for COPD through clinical phenotypes and treatable traits.
• To highlight the importance of non-pharmacological and phenotype-based pharmacological treatments.
• To emphasize the role of eosinophils as a biomarker for inhaled glucocorticoid therapy.

Summary:

• COPD diagnosis requires spirometry, but alternative screening methods are under development due to significant underdiagnosis.
• Personalized medicine utilizes clinical phenotypes and treatable traits to tailor treatments, including non-pharmacological interventions and targeted pharmacotherapy.
• Eosinophil counts are key for guiding inhaled glucocorticoid use, and monitoring exacerbation control is vital for patient prognosis.

Impact:

• Advances in COPD management through personalized treatment strategies.
• Improved patient care via tailored therapies and biomarker-guided interventions.
• Enhanced understanding of COPD exacerbations, paving the way for future research and improved clinical guidelines.